Compass Oncology, Portland, OR
Angela Kalisiak, Elizabeth Ann Gandara, Susan C Hedlund, Justin K Gress
Background: It is increasingly recognized that earlier integration of palliative care for patients with advanced cancers positively impacts both cost and quality of oncology care. Compass Oncology (CO) is a multidisciplinary community oncology practice and a member of The US Oncology Network; 39 medical, gynecologic, and radiation oncologists and 18 advance practice providers serve patients at 6 sites in Oregon and Washington. In 2008, CO prioritized practice improvement in end of life care, identifying metrics for ongoing assessment. Between 2009 and 2014, quality improvement (QI) projects focused on communication skills; whole-staff palliative care education; integration of social workers; initiation of embedded palliative care at 2 sites; and development of a more standardized approach to Advance Care Planning (ACP). Methods: Systematic retrospective record review of patient deaths from January 2009 to December 2013, targeting analysis of hospice utilization, chemotherapy use at end of life, and ACP. Results: Among patients with a CO visit within 6 months of a documented date of death (n= 783 in 2009; n= 909 in 2013), both hospice utilization and ACP participation improved significantly. Percent of patients with evidence for Advance Directive (AD), POLST or code status documented in the electronic medical record (EMR) improved from 36% in 2009 to 50 % in 2013 (p<0.001). Percent of patients enrolled in hospice at the time of death improved from 56% in 2009 to 63% in 2013 (p= 0.003). No statistically significant change was noted in % patients receiving chemotherapy in the last 14 days of life. Conclusions: Focused implementation of end of life care QI strategies in a large multidisciplinary community oncology practice appears to result in both improved hospice utilization and ACP. Chemotherapy usage in the last 14 days of life remains a meaningful target for intervention. Future QI efforts will focus on ongoing, scalable improvement in these metrics.
Metrics | 2009 | 2010 | 2011 | 2012 | 2013 |
---|---|---|---|---|---|
% Patients enrolled in hospice | 56.1 | 59.2 | 63.5 | 61.5 | 62.7 |
% Patients with AD/POLST/code status in EMR | 36.4 | 40.0 | 41.6 | 40.3 | 49.6 |
% Patients receiving chemotherapy in last 14 days of life | 9.5 | 12.7 | 12.2 | 12.9 | 9.0 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Annual Meeting
First Author: Divya Deepak
2023 ASCO Annual Meeting
First Author: Maureen Canavan
2020 ASCO Virtual Scientific Program
First Author: Cathy Zhang
2024 ASCO Quality Care Symposium
First Author: Jody S. Garey